Background
Methods
Patients
Adjuvant medications
ANA assay
IVF/ICSI protocol
Statistical analysis
Results
Basal clinical characteristics
Variables | ANA + group | ANA- group | P |
---|---|---|---|
Patients
| 66 | 233 | ns |
Age (yrs)
| 32.33 +/- 4.25 | 31.41 +/- 3.84 | ns |
BMI (kg/ m
2
)
| 21.72 +/- 2.58 | 21.77 +/- 3.04 | ns |
Duration of infertility (yrs)
| 5.06 +/- 2.66 | 4.73 +/- 3.10 | ns |
bFSH (IU/L)
| 7.15 +/- 1.84 | 7.06 +/- 2.00 | ns |
bLH (IU/L)
| 4.61 +/- 2.85 | 4.41 +/- 2.16 | ns |
bE2 (pg/ml)
| 46.41 +/- 19.60 | 48.82 +/- 19.39 | ns |
Days of ovarian stimulation
| 12.21 +/- 2.36 | 12.65 +/- 2.18 | ns |
Total Gn dose (U)
| 2464.77 +/- 78.71 | 2399.25 +/- 803.25 | ns |
E2 levels on HCG day (pg/ml)
| 3014.28 +/- 1337.26 | 2952.86 +/- 1401.69 | ns |
Endometrial thickness on HCG day (mm)
| 10.46 +/- 1.64 | 10.96 +/- 2.04 | ns |
Variables | Titre ≤1:320 | Titre > 1:320 | P |
---|---|---|---|
Patients
| 46 | 20 | - |
Age (yrs)
| 31.72 +/- 4.12 | 33.75 +/- 4.30 | ns |
BMI (kg/ m
2
)
| 21.96 +/- 2.55 | 21.16 +/- 2.63 | ns |
Duration of infertility (yrs)
| 4.98 +/- 2.65 | 5.20 +/- 2.75 | ns |
bFSH (IU/L)
| 7.00 +/- 2.02 | 7.49 +/- 1.33 | ns |
bLH (IU/L)
| 4.68 +/- 3.11 | 4.46 +/- 2.22 | ns |
bE2 (pg/ml)
| 45.97 +/- 21.09 | 47.43 +/- 16.12 | ns |
Days of ovarian stimulation
| 12.52 +/- 2.30 | 11.50 +/- 2.40 | ns |
Total Gn dose (U)
| 2553.0 +/- 838.50 | 2261.25 +/- 619.50 | ns |
E2 levels on the HCG day (pg/ml)
| 3017.61 +/- 1404.05 | 3006.64 +/- 1203.62 | ns |
Endometrial thickness on HCG day (mm)
| 10.40 +/- 1.74 | 10.60 +/- 1.42 | ns |
Variables | Without P + A | With P + A | P |
---|---|---|---|
Patients
| 21 | 21 | - |
Age (yrs)
| 31.71 +/- 3.61 | - | - |
BMI (kg/ m
2
)
| 21.53 +/- 2.23 | - | - |
Duration of infertility (yrs)
| 4.62 +/- 2.44 | - | - |
bFSH (IU/L)
| 7.38 +/- 2.10 | - | - |
bLH (IU/L)
| 4.57 +/- 2.46 | - | - |
bE2 (pg/ml)
| 52.85 +/- 24.40 | - | - |
Days of ovarian stimulation
| 12.22 +/- 2.14 | 11.95 +/- 2.13 | ns |
Total Gn dose (U)
| 2719.64 +/- 808.35 | 2567.86 +/- 722.85 | ns |
E2 levels on HCG day (pg/ml)
| 2704.12 +/- 1305.23 | 3139.39 +/- 1417.05 | ns |
Endometrial thickness on HCG day (mm)
| 10.58+/- 1.93 | 10.59 +/- 2.59 | ns |
Fertilisation and embryo development in the ANA + group and the ANA- group
Variables | ANA + group | ANA- group | P |
---|---|---|---|
OPU cycles (IVF + ICSI)
| 66 (28 + 38) | 233 (106 + 127) | - |
ET cycles
| 52 | 184 | ns |
Proportion of ICSI program (%)
| 57.6 (38/66) | 54.5 (127/233) | ns |
Semen volume (ml, ICSI cycles)
| 3.46+/-0.74 | 3.96+/-0.86 | ns |
Sperm concentration (×106/ml, ICSI cycles)
| 16.86+/-13.34 | 15.45+/-11.23 | ns |
Sperm progressive motility (%, ICSI cycles)
| 11.97+/-9.74 | 10.96+/-8.44 | ns |
Semen volume (ml, IVF cycles)
| 3.67+/-0.87 | 3.86+/-0.84 | ns |
Sperm concentration (×106/ml, IVF cycles)
| 65.33+/-44.33 | 68.84+/-46.00 | ns |
Sperm progressive motility (%, IVF cycles)
| 40.28+/-16.78 | 35.23+/-15.84 | ns |
Retrieved oocytes
| 9.73 +/- 5.03 | 10.38 +/- 4.15 | ns |
MII oocytes rate (%, ICSI cycle)
| 78.1 (285/365) | 82.6 (1112/1346) | 0.047 |
Normal fertilisation rate (%, ICSI cycle)
| 70.5 (201/285) | 83.1 (924/1112) | <0.001 |
Abnormal fertilisation rate (%, ICSI cycle)
| 4.91 (14/285) | 0.36 (4/1112) | <0.001 |
Normal fertilisation rate (%, IVF cycle)
| 66.1 (183/277) | 76.0 (815/1073) | <0.001 |
Abnormal fertilisation rate (%, IVF cycle)
| 4.33 (12/277) | 2.33 (23/1073) | 0.041 |
Cleavage rate (%)
| 97.7 (375/384) | 98.5 (1713/1739) | ns |
Perfect embryo rate (%)
| 63.7 (239/375) | 66.5 (1139/1713) | ns |
Available embryo rate (%)
| 78.7 (295/375) | 82.9 (1420/1713) | ns |
Transferred embryos/cycle
| 2.12 ± 0.55 | 2.11 ± 0.38 | ns |
IVF/ICSI outcomes in the ANA + group and the ANA- group
Fertilisation and embryo development in the titre ≤ 1:320 subgroup and the titre > 1:320 subgroup
Variables | Titre ≤ 1:320 | Titre > 1:320 | P |
---|---|---|---|
OPU cycles
| 46 | 20 | - |
ET cycles
| 33 | 19 | - |
Retrieved oocytes
| 9.96 +/- 5.04 | 9.20 +/- 5.08 | ns |
MII oocytes rate (%, ICSI cycle)
| 80.4 (193/240) | 73.6 (92/125) | ns |
Normal fertilisation rate (%, ICSI cycle)
| 73.6 (142/193) | 64.1 (59/92) | ns |
Abnormal fertilisation rate (%, ICSI cycle)
| 5.18 (10/193) | 4.35 (4/92) | ns |
Normal fertilisation rate (%, IVF cycle)
| 68.3 (149/218) | 57.6 (34/59) | ns |
Abnormal fertilisation rate (%, IVF cycle)
| 2.75 (6/218) | 10.2 (6/59) | 0.034 |
Cleavage rate (%)
| 97.6 (284/291) | 97.8 (91/93) | ns |
Perfect embryo rate (%)
| 63.7 (181/284) | 63.7 (58/91) | ns |
Available embryo rate (%)
| 78.2 (222/284) | 80.2 (73/91) | ns |
Transferred embryos/cycle
| 2.09 +/- 0.46 | 2.16 +/- 0.69 | ns |
IVF/ICSI outcomes in the titre ≤ 1:320 subgroup and the Titre > 1:320 subgroup
Fertilisation, embryo development and outcomes in the ANA + cycles without P + A and the ANA + cycles with P + A
Variables | Without P + A | With P + A | P |
---|---|---|---|
OPU cycles (IVF + ICSI)
| 21(11 + 10) | 21 (11 + 10) | - |
ET cycles
| 16 | 21 | - |
Semen volume (ml, ICSI cycles)
| 3.54+/-0.81 | 3.09+/-0.87 | ns |
Sperm concentration (×106/ml, ICSI cycles)
| 14.64+/-11.21 | 16.34+/-10.65 | ns |
Sperm progressive motility (%, ICSI cycles)
| 12.87+/-10.97 | 15.34+/-11.56 | ns |
Semen volume (ml, IVF cycles)
| 3.44+/-0.93 | 3.64+/-0.83 | ns |
Sperm concentration (×106/ml, IVF cycles)
| 62.56+/-43.78 | 66.23+/-39.23 | ns |
Sperm progressive motility (%, IVF cycles)
| 46.89+/-15.45 | 43.89+/-17.68 | ns |
Retrieved oocytes
| 8.10 +/- 3.95 | 9.24 +/- 4.10 | ns |
MII oocytes
| 6.50 +/- 4.09 | 7.20 +/- 3.99 | ns |
Two pro-nuclei
| 4.86 +/- 2.89 | 7.05 +/- 3.17 | 0.004 |
Perfect embryos
| 3.24 +/- 2.41 | 4.76 +/- 2.93 | 0.037 |
Available embryos
| 3.62 +/- 2.22 | 5.76 +/- 3.25 | 0.008 |
Embryos
| 4.81 +/- 2.93 | 6.90 +/- 3.24 | 0.006 |
Transferred embryos/cycle
| 2.06 +/- 0.44 | 2.76 +/- 0.58 | 0.008 |
Pregnancy rate (%)
| 12.5 (2/16) | 57.1% (12/21) | 0.006 |
Implantation rate (%)
| 6.06 (2/33) | 27.9 (16/58) | 0.013 |
Early miscarriage rate (%)
| 100 (2/2) | 25 (3/12) | - |